StockData
Viatris Inc logo

Viatris Inc

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.63−0.25 (-1.26%)

Close on Nov 20, 2026Market cap $22.55BP/E –Yield 2.45%

Viatris UTB Reductions by Year

UTB Reductions — Settlements with Taxing Authorities ($M)

Viatris UTB Reductions: $19.1M in FY2025, up 22.4% from a year earlier.

Latest, FY2025
19.1
Period ended Dec 31, 2025
Change on a year earlier
+22.4%
15.6 in FY2024
History
10 years
Since FY2016
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: SEC Form 10-K (2026-02-26) ↗

Reported in SEC Form 10-K Income Taxes Note.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUTB Reductions — Settlements with Taxing Authorities ($M)Year on yearSource
FY2025Dec 31, 202519.1+22.4%SEC Form 10-K (2026-02-26) ↗
FY2024Dec 31, 202415.6+642.9%SEC Form 10-K (2026-02-26) ↗
FY2023Dec 31, 20232.10+425.0%SEC Form 10-K (2026-02-26) ↗
FY2022Dec 31, 20220.40-99.2%SEC Form 10-K (2025-02-27) ↗
FY2021Dec 31, 202147.30.0%SEC Form 10-K (2024-02-28) ↗
FY2020Dec 31, 202047.3+431.5%SEC Form 10-K (2023-02-27) ↗
FY2019Dec 31, 20198.900.0%SEC Form 10-K (2022-02-28) ↗
FY2018Dec 31, 20188.90-92.1%SEC Form 10-K (2023-02-27) ↗
FY2017Dec 31, 2017113+241.9%SEC Form 10-K (2022-02-28) ↗
FY2016Dec 31, 201632.9–SEC Form 10-K (2021-03-01) ↗

Cite this data

StockData. (2026). Viatris UTB Reductions ($M), annual FY2016–FY2025 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/utb-dec-settle

See every metric in the Viatris KPI table. Data updated Nov 16, 2026.

See a number that looks wrong?